Isis Pharmaceuticals (ISIS -6%) dips on a downgrade to Neutral this morning from Summer Street,...

|By:, SA News Editor

Isis Pharmaceuticals (ISIS -6%) dips on a downgrade to Neutral this morning from Summer Street, saying it sees only a 50% chance the FDA panel will vote to approve it hypercholesterolemia drug Kynamro.